| CAS ID: | 11145-52-1 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Protein based biotech |
| Natural Product: | No |
| Other Names: | GENOTROPIN PRESERVATIVE FREE | CRESCORMON | ACCRETROPIN | OMNITROPE PEN 10 | NUTROPIN | NORDITROPIN | GENOTROPIN KABIQUICK | BIO-TROPIN | Tev-Tropin | OMNITROPE SUREPAL 15 | NUTROPINAQ | NUTROPIN AQ | NORDITROPIN PENSET | OMNITROPE PEN 5 | OMNITROPE | ASELLACRIN 2 | SEROSTIM | ZORBTIVE | SAIZEN EASYJECT | OMNITROPE SUREPAL 10 | NORDITROPIN NORDIFLEX | NORDITROPIN FLEXPRO | SEROSTIM LQ | SAIZEN CLICK.EASY | SAIZEN | NUTROPIN AQ NUSPIN | NORDITROPIN SIMPLEXX | Genotropin [rDNA origin] | GENOTROPIN KABIPEN | VALTROPIN | SOMATROPIN | NUTROPIN DEPOT | NUTROPIN AQ PEN | HumatroPen | GENOTROPIN GOQUICK | GENOTROPIN | CB-311 | ASELLACRIN 10 | ZOMACTON | SOMATROPIN RECOMBINANT | OMNITROPE SUREPAL 5 | HUMATROPE | GENOTROPIN MINIQUICK | GENOTROPIN KABIVIAL |
| Analysis: | N/A |
Trial Record 1
| ClinicalTrial ID | NCT00079742 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | March 16, 2004 | Last Verified | June 9, 2008 |
| Sponsor | Genentech, Inc. | ||
Trial Record 2
| ClinicalTrial ID | NCT00803179 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Terminated |
| First Received | December 5, 2008 | Last Verified | January 15, 2013 |
| Sponsor | University of Massachusetts, Worcester | ||
Trial Record 3
| ClinicalTrial ID | NCT00256555 | Disease | Cystic fibrosis |
| Phase | Phase 2,Phase 3 | Status | Withdrawn |
| First Received | November 21, 2005 | Last Verified | January 10, 2019 |
| Sponsor | University of Texas Southwestern Medical Center | ||
| PubChem: | 135274454 |
| ChEMBL: | CHEMBL1201621 |